As per the study initiated by Evolve Business Intelligence, the global Vaccine market size accounted for USD 70.2 Billion in 2022, growing at a CAGR of 12.4% from 2023 to 2033. The vaccine market refers to the industry segment involved in the research, development, manufacturing, and distribution of vaccines. Vaccines are biological products designed to stimulate the immune system and provide immunity against specific infectious diseases. They play a crucial role in preventing and controlling the spread of infectious diseases, thereby protecting public health. The vaccine market has experienced significant growth in recent years, driven by factors such as increased investments in research and development, rising healthcare expenditure, growing awareness about the importance of immunization, and expanded vaccination programs globally. The market size is substantial, and it is expected to continue growing as new vaccines are developed and deployed.
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=xherald&reportCode=019481
- The global Vaccine Market size was valued at USD 2 billion in 2022 growing at a CAGR of 12.4% from 2023 to 2033.
- North America dominated the market in 2022
- Asia Pacific is expected to fastest-growing at the highest CAGR from 2023 to 2033
Evolve Business Intelligence has published a new market research report on Global Vaccine Market focusing in various aspects including market size and forecast, market dynamics, competitors market share analysis, market size in terms of value and volume, SWOT analysis, product benchmarking, key players recent developments, and opportunities, among others. The market has also been analyzed based on 4 indicators in the market dynamic chapter which includes Drivers, Restraints, Key Trends, and Challenges. The overall sum of these sections will help to understand the best strategies to be adopted in order to prosper through this industry over short and long terms. The quantitative analysis includes our authentic findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.
In terms of COVID 19 impact, the Vaccine market report also includes the following data points:
- COVID19 Impact on Vaccine market size
- End-User/Industry/Application Trend, and Preferences
- Government Policies/Regulatory Framework
- Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
- Opportunity in Vaccine market
Buy Latest Copy of Report Now at Higher Discount: https://report.evolvebi.com/index.php/sample/request?referer=xherald&reportCode=019481
Some of the major Vaccine players holding high market share include Merck & Co., Inc, Pfizer Inc., GSK plc, and Sanofi. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders.
The key players profiled in the report are:
- Merck & Co., Inc.
- Pfizer Inc.
- GSK plc
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Private Limited
- Indian Immunologicals Ltd.
- Charles River Laboratories
- uniQure N.V.
- Waisman Biomanufacturing
Market Segment By Type with focus on market share, consumption trend, and growth rate of Vaccine Market:
- Conjugate Vaccines
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- DNA Vaccines
Market Segment By Disease with focus on market share, consumption trend, and growth rate of Vaccine Market:
- Pneumococcal Disease
- Japanese Encephalitis
- Yellow Fever
Market Segment By end-user with a focus on market share, consumption trend, and growth rate of the Vaccine Market:
- Community Hospitals
- Specialty Centres
|Market Size (2022)||$ 70.2 Billion|
|CAGR (2023 to 2033)||12.4%|
|Market Segmentation||Type, Disease, End User|
|Country Covered||US, Canada, Mexico, UK, Germany, France, Italy, Spain, Nordic Countries, BeNeLux, Rest of Europe, China, India, Japan, South Korea, Indonesia, Malaysia, Australia, Rest of Asia Pacific, Middle East & Africa, and South America|
For more information: https://report.evolvebi.com/index.php/sample/request?referer=xherald&reportCode=019481
Global Vaccine Geographic Coverage:
- North America
- Nordic Countries
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of MEA
- Latin America
- Rest of Latin America
Reasons to Buy this Report:
- Detail analysis of the impact of market drivers, restraints, and opportunities
- Competitive Intelligence provides an understanding of the ecosystem
- Details analysis of the Total Addressable Market (TAM) of your products
- Investment Pockets and New Business Opportunities
- Demand-supply gap analysis
- Strategy Planning
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.
Evolve Business Intelligence
C-218, 2nd floor, M-Cube